CBLN1 and Alzheimer disease: For example, Han et al. [41] showed that plasma Cer d18:1/16:0 was approximately 1.27-fold significantly increased in AD patients compared to controls, while a more recent study that evaluated plasma of autopsy-confirmed AD dementia patients reported a 1.21-fold increase of the same ceramide species [60].